49
Participants
Start Date
December 25, 2018
Primary Completion Date
July 7, 2020
Study Completion Date
July 7, 2020
BCD-100
Anti-PD-1 monoclonal antibody, IV infusion
Bevacizumab
IV infusion
Paclitaxel
IV infusion
Cisplatin (or carboplatin)
IV infusion
RECRUITING
Moscow Clinical Scientific and Practical Center named A.S. Loginova, Moscow
RECRUITING
N.N. Blokhin National Medical Research Center of Oncology (2), Moscow
RECRUITING
N.N. Blokhin National Medical Research Center of Oncology, Moscow
RECRUITING
"JSC Medsi Group of Companies", Moscow
RECRUITING
Moscow City Oncology Hospital No. 62, Moscow
RECRUITING
Regional Clinical Oncology Hospital, Yaroslavl
RECRUITING
Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk
RECRUITING
Murmansk Regional Clinical Hospital named after P.A. Bayandina, Murmansk
RECRUITING
"JSC Modern Medical Technologies", Saint Petersburg
RECRUITING
"LLC AB Medical Group", Saint Petersburg
RECRUITING
N.N. Petrov National Medical Research Center of Oncology (2), Saint Petersburg
RECRUITING
N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg
RECRUITING
Saint-Petersburg Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological), Saint Petersburg
RECRUITING
National Medical Radiology Research Center, Obninsk
RECRUITING
Clinical Oncologic Dispensary No. 1, Krasnodar
RECRUITING
Stavropol Regional Clinical Oncology Center, Stavropol
RECRUITING
"LLC New Clinic", Pyatigorsk
RECRUITING
Republican Clinical Oncology Cente, Kazan'
RECRUITING
Republican Oncology Center, Saransk
RECRUITING
Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine, Chelyabinsk
RECRUITING
Sverdlovsk Regional Oncology Center, Yekaterinburg
RECRUITING
Clinical Oncology Dispensary, Omsk
RECRUITING
City Hospital No. 5, Barnaul
RECRUITING
Krasnoyarsk Regional Clinical Oncological Dispensary named after A.I. Kryzhanovsky, Krasnoyarsk
Lead Sponsor
Biocad
INDUSTRY